U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07116889) titled 'A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD' on July 23.
Brief Summary: This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.
Study Start Date: Dec. 12, 2023
Study Type: INTERVENTIONAL
Condition:
Asthma
COPD (Chronic Obstructive Pulmonary Disease)
Intervention:
BIOLOGICAL: GB-0895 (SC)
Single subcutaneous dose of GB-0895
BIOLOGICAL: GB-0895 (SC)
Multiple subcutaneous doses of GB-0895
DRUG: Placebo (SC)
Single subcutaneous dose of placebo
DRUG: Placebo (SC)
Multiple subcutaneous doses of placebo
Recruitment Status: RECRUITING
Sponsor: Generat...